BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6996251)

  • 1. [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].
    Lumholtz IB; Thorsteinsson B; Wamberg T; Lehnschau A; Hansen G; Spellerberg S; Lund B
    Ugeskr Laeger; 1980 Jun; 142(23):1487-90. PubMed ID: 6996251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Elsinore tablets and ephedrine as slimming agents].
    Jensen KB; Danø P; Draeby N; Hansen SH; Kanstrup J
    Ugeskr Laeger; 1980 Jun; 142(23):1499-501. PubMed ID: 6996254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elsinore banting tablets. A controlled clinical trial in general practice].
    Roed P; Hansen PW; Bidstrup B; Kaern M; Helles A; Petersen KP
    Ugeskr Laeger; 1980 Jun; 142(23):1491-5. PubMed ID: 6996252
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial using ephedrine in the treatment of obesity.
    Pasquali R; Baraldi G; Cesari MP; Melchionda N; Zamboni M; Stefanini C; Raitano A
    Int J Obes; 1985; 9(2):93-8. PubMed ID: 3897082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weight loss by treatment with Fugoa depot. Results of a double blind study].
    Muth H; Issmeier G
    Ther Ggw; 1980 Oct; 119(10):1173-83. PubMed ID: 7008236
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 8. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
    Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ephedrine promote weight loss in low-energy-adapted obese women?
    Pasquali R; Cesari MP; Melchionda N; Stefanini C; Raitano A; Labo G
    Int J Obes; 1987; 11(2):163-8. PubMed ID: 3301709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of obesity. The initial and continued effectiveness of tenuate in intermittent therapy of moderately and severely obese patients. Double-blind study].
    Albach E; Gianoli AC
    Fortschr Med; 1977 Sep; 95(33):2040-4. PubMed ID: 334650
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S; Astrup AV; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fiber tablets, DumoVital - an aid to start weight reduction].
    Solum TT
    Tidsskr Nor Laegeforen; 1983 Aug; 103(24):1707-8. PubMed ID: 6314590
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
    González Barranco J; Rull JA; Lozano Castañeda O
    Prensa Med Mex; 1974; 39(5-6):298-9. PubMed ID: 4612507
    [No Abstract]   [Full Text] [Related]  

  • 17. Metaproterenol tablets: their duration of effect by comparison with ephedrine.
    Chervinsky P; Chervinsky G
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):507-18. PubMed ID: 808372
    [No Abstract]   [Full Text] [Related]  

  • 18. No effect of activated charcoal on hyperlipidaemia. A double-blind prospective trial.
    Hoekstra JB; Erkelens DW
    Neth J Med; 1988 Dec; 33(5-6):209-16. PubMed ID: 3065658
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].
    Quaade F; Astrup A; Breum L; Toubro S; Hein P
    Ugeskr Laeger; 1992 Apr; 154(18):1258-63. PubMed ID: 1598695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.